Skip to main content
SpringerLink
Log in

Clinical Applications of Liver Magnetic Resonance Elastography: Chronic Liver Disease

  • Chapter
  • First Online:
Magnetic Resonance Elastography

Abstract

The most widely used clinical application of Magnetic Resonance Elastography (MRE) is in the evaluation of chronic liver disease (CLD). Currently, MRE is the most accurate non-invasive technique for detection and staging of liver fibrosis and potential non-invasive alternative to liver biopsy. MRE is a robust technique with excellent repeatability and reproducibility of liver stiffness. Since its introduction as a clinical tool for assessment of liver fibrosis, several indications have emerged including longitudinal follow up of CLD, prediction of liver decompensation, assessment of portal hypertension, evaluation of treatment response and for differentiation of non-alcoholic fatty liver (NAFL) from nonalcoholic steatohepatitis (NASH). Other potential applications of MRE of liver include assessment for fibrosis in patients receiving hepatotoxic drugs and in congestive hepatopathy. MRE of liver is a dynamic field with ongoing improvements in the technique and continued emergence of newer clinical applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Venkatesh SK, Yin M, Talwalkar JA, Ehman RL, editors. Application of liver MR elastography in clinical practice. In: Proceedings of 17th annual meeting of ISMRM, Toronto; 2008 (abstract 2611).

    Google Scholar 

  2. Chu CM, Liaw YF. Hepatitis B virus-related cirrhosis: natural history and treatment. Semin Liver Dis. 2006;26(2):142–52.

    PubMed  CAS  Google Scholar 

  3. Liver EAFTSOT. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167–85.

    Google Scholar 

  4. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. Diseases AAfSoL. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(4)):1433–44.

    PubMed  PubMed Central  Google Scholar 

  5. Castéra L, Nègre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology. 1999;30(6):1529–30.

    PubMed  Google Scholar 

  6. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986;2(2):165–73.

    PubMed  CAS  Google Scholar 

  7. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344(7):495–500.

    PubMed  CAS  Google Scholar 

  8. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the group of epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32(3):477–81.

    PubMed  CAS  Google Scholar 

  9. Regev A, Berho M, Jeffers L, Milikowski C, Molina E, Pyrsopoulos N, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97(10):2614–8.

    PubMed  Google Scholar 

  10. Maharaj B, Maharaj R, Leary W, Cooppan R, Naran A, Pirie D, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet. 1986;1(8480):523–5.

    PubMed  CAS  Google Scholar 

  11. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38(6):1449–57.

    PubMed  Google Scholar 

  12. Rousselet MC, Michalak S, Dupré F, Croué A, Bedossa P, Saint-André JP, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology. 2005;41(2):257–64.

    PubMed  Google Scholar 

  13. Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY. Performance of the aspartate aminotrasnferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis:an updated meta-analysis. hepatology 2011;53(3):726–36.

    Google Scholar 

  14. Halfon P, Bacq Y, De Muret A, Penaranda G, Bourliere M, Ouzan D, et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol. 2007;46(3):395–402.

    PubMed  Google Scholar 

  15. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142(6):1293–302.e4.

    PubMed  Google Scholar 

  16. Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology. 2006;43(2 Suppl 1):S113–20.

    PubMed  CAS  Google Scholar 

  17. Castera L. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol. 2011;25(2):291–303.

    PubMed  CAS  Google Scholar 

  18. Venkatesh SK, Takahashi N, Glocker JF, Yin M, Talwalkar JA, Grimm RC, et al., editors. Non-invasive diagnosis of liver fibrosis: conventional MR imaging findings versus MR elastography. In: Proceedings of 17th annual meeting of ISMRM, Toronto; 2008 (abstract 2613); Toronto: ISMRM.

    Google Scholar 

  19. Rustogi R, Horowitz J, Harmath C, Wang Y, Chalian H, Ganger DR, et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging. 2012;35(6):1356–64.

    PubMed  PubMed Central  Google Scholar 

  20. Martí-Bonmatí L, Delgado F. MR imaging in liver cirrhosis: classical and new approaches. Insights Imaging. 2010;1(4):233–44.

    PubMed  PubMed Central  Google Scholar 

  21. Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007;5(10):1207–13.e2.

    PubMed  PubMed Central  Google Scholar 

  22. Huwart L, Peeters F, Sinkus R, Annet L, Salameh N, ter Beek LC, et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed. 2006;19(2):173–9.

    PubMed  Google Scholar 

  23. Huwart L, Sempoux C, Salameh N, Jamart J, Annet L, Sinkus R, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 2007;245(2):458–66.

    PubMed  Google Scholar 

  24. Huwart L, Sempoux C, Vicaut E, Salameh N, Annet L, Danse E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology. 2008;135(1):32–40.

    PubMed  Google Scholar 

  25. Venkatesh SK, Wang G, Lim SG, Wee A. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol. 2014;24(1):70–8.

    PubMed  Google Scholar 

  26. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Enomoto N, et al. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci. 2012;11(4):291–7.

    PubMed  Google Scholar 

  27. Binkovitz LA, El-Youssef M, Glaser KJ, Yin M, Binkovitz AK, Ehman RL. Pediatric MR elastography of hepatic fibrosis: principles, technique and early clinical experience. Pediatr Radiol. 2012;42(4):402–9.

    PubMed  PubMed Central  Google Scholar 

  28. Venkatesh SK, Teo LLS, Ang BWL, Lim SG, Wee A, Ehman RL. Effect of intravenous gadolinium on estimation of liver stiffness with MR elastography. European Congress of Radiology 2010. Vienna: European Society of Radiology; 2010. p. 163.

    Google Scholar 

  29. Motosugi U, Ichikawa T, Sou H, Sano K, Muhi A, Ehman RL, et al. Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography. Magn Reson Imaging. 2012;30(1):128–32.

    PubMed  CAS  PubMed Central  Google Scholar 

  30. Shire NJ, Yin M, Chen J, Railkar RA, Fox-Bosetti S, Johnson SM, et al. Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C. J Magn Reson Imaging. 2011;34(4):947–55.

    PubMed  PubMed Central  Google Scholar 

  31. Hines CD, Bley TA, Lindstrom MJ, Reeder SB. Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging. 2010;31(3):725–31.

    PubMed  PubMed Central  Google Scholar 

  32. Venkatesh SK, Wang G, Lim SG, Wee A. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol. 2014;24(1):70–8.

    PubMed  Google Scholar 

  33. Godfrey EM, Patterson AJ, Priest AN, Davies SE, Joubert I, Krishnan AS, et al. A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol. 2012;22(12):2790–7.

    PubMed  Google Scholar 

  34. Motosugi U, Ichikawa T, Sano K, Sou H, Muhi A, Koshiishi T, et al. Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability. Jpn J Radiol. 2010;28(8):623–7.

    PubMed  Google Scholar 

  35. Runge JH, Bohte AE, Verheij J, Terpstra V, Nederveen AJ, van Nieuwkerk KM, et al. Comparison of interobserver agreement of magnetic resonance elastography with histopathological staging of liver fibrosis. Abdom Imaging. 2014;39(2):283–90.

    PubMed  Google Scholar 

  36. Blouin A, Bolender RP, Weibel ER. Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol. 1977;72(2):441–55.

    PubMed  CAS  Google Scholar 

  37. Wisse E, Braet F, Luo D, De Zanger R, Jans D, Crabbé E, et al. Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol. 1996;24(1):100–11.

    PubMed  CAS  Google Scholar 

  38. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis. 1990;10(1):1–10.

    PubMed  CAS  Google Scholar 

  39. Rojkind M, Ponce-Noyola P. The extracellular matrix of the liver. Coll Relat Res. 1982;2(2):151–75.

    PubMed  CAS  Google Scholar 

  40. Biagini G, Ballardini G. Liver fibrosis and extracellular matrix. J Hepatol. 1989;8(1):115–24.

    PubMed  CAS  Google Scholar 

  41. Greenway C, Lautt WW. The hepatic circulation. In: Schultz S, editor. Handbook of physiology, vol. 1. Bethesda: American Physiological Society; 1989. p. 1519–64.

    Google Scholar 

  42. Nakata K. Microcirculation and hemodynamic analysis of the blood circulation of the liver. Acta Pathol Jpn. 1967;17(3):361–76.

    PubMed  CAS  Google Scholar 

  43. Nakata K, Leong GF, Brauer RW. Direct measurement of blood pressures in minute vessels of the liver. Am J Physiol. 1960;199:1181–8.

    PubMed  CAS  Google Scholar 

  44. Barrett KE, Boitano S, Barman SM, Brooks HL. Barrett K.E., Boitano S, Barman S.M., Brooks H.L. Chapter 28. Transport & Metabolic Functions of the Liver. In: Barrett KE, Boitano S, Barman SM, Brooks HL. Barrett K.E., Boitano S, Barman S.M., Brooks H.L. eds. Ganong’s Review of Medical Physiology, 24e. New York, NY: McGraw-Hill; 2012. http://accessmedicine.mhmedical.com/content.aspx?bookid=393&Sectionid=39736772. Accessed August 07, 2014.

  45. Rappaport AM. Microcirculatory units in the mammalian liver. Their arterial and portal components. Bibl Anat. 1977;16 Pt 2:116–20.

    PubMed  Google Scholar 

  46. Lautt WW, Greenway CV. Hepatic venous compliance and role of liver as a blood reservoir. Am J Physiol. 1976;231(2):292–5.

    PubMed  CAS  Google Scholar 

  47. Lautt WW, Greenway CV, Legare DJ. Index of contractility: quantitative analysis of hepatic venous distensibility. Am J Physiol. 1991;260(2 Pt 1):G325–32.

    PubMed  CAS  Google Scholar 

  48. Lautt WW, Legare DJ. Passive autoregulation of portal venous pressure: distensible hepatic resistance. Am J Physiol. 1992;263(5 Pt 1):G702–8.

    PubMed  CAS  Google Scholar 

  49. Bennett TD, Rothe CF. Hepatic capacitance responses to changes in flow and hepatic venous pressure in dogs. Am J Physiol. 1981;240(1):H18–28.

    PubMed  CAS  Google Scholar 

  50. Venkatesh SK, Wang G, Teo LL, Ang BW. Magnetic resonance elastography of liver in healthy Asians: Normal liver stiffness quantification and reproducibility assessment. J Magn Reson Imaging. 2014;39(1):1–8.

    PubMed  Google Scholar 

  51. Lee DH, Lee JM, Han JK, Choi BI. MR elastography of healthy liver parenchyma: Normal value and reliability of the liver stiffness value measurement. J Magn Reson Imaging. 2013;38(5):1215–23.

    PubMed  Google Scholar 

  52. Kim BH, Lee JM, Lee YJ, Lee KB, Suh KS, Han JK, et al. MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. J Magn Reson Imaging. 2011;34(5):1110–6.

    PubMed  Google Scholar 

  53. Herzka D, Kotys M, Sinkus R, Pettigrew R, Gharib A. Magnetic resonance elastography in the liver at 3 Tesla using a second harmonic approach. Magn Reson Med. 2009;62(2):284–91.

    PubMed  CAS  Google Scholar 

  54. Mannelli L, Godfrey E, Graves MJ, Patterson AJ, Beddy P, Bowden D, et al. Magnetic resonance elastography: feasibility of liver stiffness measurements in healthy volunteers at 3T. Clin Radiol. 2012;67(3):258–62.

    PubMed  CAS  Google Scholar 

  55. Hines CD, Lindstrom MJ, Varma AK, Reeder SB. Effects of postprandial state and mesenteric blood flow on the repeatability of MR elastography in asymptomatic subjects. J Magn Reson Imaging. 2011;33(1):239–44.

    PubMed  Google Scholar 

  56. Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis. 2004;36(4):231–42.

    PubMed  CAS  Google Scholar 

  57. Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 2005;42(Suppl(1)):S22–36.

    PubMed  Google Scholar 

  58. Friedman SL. Liver fibrosis – from bench to bedside. J Hepatol. 2003;38 Suppl 1:S38–53.

    PubMed  Google Scholar 

  59. Goodman Z, Becker RJ, Pockros P, Afdhal N. Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology. 2007;45(4):886–94.

    PubMed  CAS  Google Scholar 

  60. Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl. 2004;10(10):1248–55.

    PubMed  Google Scholar 

  61. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology. 1999;30(4):1054–8.

    PubMed  CAS  Google Scholar 

  62. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19(12):1409–17.

    PubMed  CAS  Google Scholar 

  63. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696–9.

    PubMed  CAS  Google Scholar 

  64. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24(2):289–93.

    PubMed  CAS  Google Scholar 

  65. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467–74.

    PubMed  CAS  Google Scholar 

  66. Guido M. Chronic hepatitis: grading and staging. In: Saxena R, editor. Practical hepatic pathology: a diagnostic approach. St. Louis: WB Sanders; 2011. p. 201–13.

    Google Scholar 

  67. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut. 2006;55(4):569–78.

    PubMed  CAS  PubMed Central  Google Scholar 

  68. Venkatesh SK, Xu S, Tai D, Yu H, Wee A. Correlation of MR elastography with morphometric quantification of liver fibrosis (Fibro-C-Index) in chronic hepatitis B. Magn Reson Med. 2013. doi:10.1002/mrm.25002

  69. Vizzotto L, Vertemati M, Gambacorta M, Sabatella G, Spina V, Minola E. Analysis of histological and immunohistochemical patterns of the liver in posthepatitic and alcoholic cirrhosis by computerized morphometry. Mod Pathol. 2002;15(8):798–806.

    PubMed  Google Scholar 

  70. Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O, Yano M. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology. 1997;25(4):1028–31.

    PubMed  CAS  Google Scholar 

  71. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Lédinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009;29(2):242–7.

    PubMed  Google Scholar 

  72. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996;23(6):1334–40.

    PubMed  CAS  Google Scholar 

  73. Silva AC, Walker W, Vargas V, Jatoi J, Ehman E, editors. Diffuse liver disease: virtual palpation with MR elastography. In: Proceedings of the radiological society of North America 93rd scientific assembly and annual meeting; 2008; Chicago.

    Google Scholar 

  74. Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: clinical applications. J Comput Assist Tomogr. 2013;37(6):887–96.

    PubMed  PubMed Central  Google Scholar 

  75. Asbach P, Klatt D, Schlosser B, Biermer M, Muche M, Rieger A, et al. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology. 2010;257(1):80–6.

    PubMed  Google Scholar 

  76. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology. 2011;259(3):749–56.

    PubMed  PubMed Central  Google Scholar 

  77. Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging. 2013;37(3):544–55.

    PubMed  PubMed Central  Google Scholar 

  78. Bohte AE, van Dussen L, Akkerman EM, Nederveen AJ, Sinkus R, Jansen PLM, et al. Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage. PLoS One. 2013;8(3):e57507.

    PubMed  CAS  PubMed Central  Google Scholar 

  79. Bensamoun SF, Leclerc GE, Debernard L, Cheng X, Robert L, Charleux F, et al. Cutoff values for alcoholic liver fibrosis using magnetic resonance elastography technique. Alcohol Clin Exp Res. 2013;37(5):811–7.

    PubMed  CAS  Google Scholar 

  80. Crespo S, Bridges M, Nakhleh R, McPhail A, Pungpapong S, Keaveny AP. Non-invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C. Clin Transplant. 2013;27(5):652–8.

    PubMed  CAS  Google Scholar 

  81. Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, Elkashab M. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int. 2010;30(10):1471–80.

    PubMed  Google Scholar 

  82. Singh S, Fujii LL, Murad MH, Wang Z, Asrani SK, Ehman RL, et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(12):1573–84.e1-2. quiz e88-9.

    PubMed  Google Scholar 

  83. Asrani SK, Talwalkar JA, Kamath PS, Shah VH, Saracino G, Jennings L, et al. Role of magnetic resonance elastography in compensated and decompensated liver disease. J Hepatol. 2013;60(5):934–9.

    PubMed  Google Scholar 

  84. Sanyal AJ. NASH: a global health problem. Hepatol Res. 2011;41(7):670–4.

    PubMed  Google Scholar 

  85. Younossi ZM, Stepanova M, Rafiq N, Makhlouf H, Younoszai Z, Agrawal R, et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology. 2011;53(6):1874–82.

    PubMed  Google Scholar 

  86. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7(2):234–8.

    PubMed  Google Scholar 

  87. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43(8):617–49.

    PubMed  Google Scholar 

  88. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–85.

    PubMed  CAS  Google Scholar 

  89. Venkatesh SK, Wang G, Teo LL, Ang BW. Magnetic resonance elastography of liver in healthy asians: normal liver stiffness quantification and reproducibility assessment. J Magn Reson Imaging. 2014;39(1):1–8.

    PubMed  Google Scholar 

  90. Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology. 2013;268(2):411–9.

    PubMed  PubMed Central  Google Scholar 

  91. Manabe N, Chevallier M, Chossegros P, Causse X, Guerret S, Trépo C, et al. Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation. Hepatology. 1993;18(6):1344–9.

    PubMed  CAS  Google Scholar 

  92. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol. 2003;38(3):257–65.

    PubMed  CAS  Google Scholar 

  93. Caballero T, Pérez-Milena A, Masseroli M, O’Valle F, Salmerón FJ, Del Moral RM, et al. Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C. J Hepatol. 2001;34(5):740–7.

    PubMed  CAS  Google Scholar 

  94. Sakaida I, Nagatomi A, Hironaka K, Uchida K, Okita K. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy. Am J Gastroenterol. 1999;94(2):489–96.

    PubMed  CAS  Google Scholar 

  95. Duchatelle V, Marcellin P, Giostra E, Bregeaud L, Pouteau M, Boyer N, et al. Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method. J Hepatol. 1998;29(1):20–8.

    PubMed  CAS  Google Scholar 

  96. Friedman S, Bansal M. Reversal of hepatic fibrosis – fact or fantasy? Hepatology. 2006;43(2 Suppl 1):S82–8.

    PubMed  CAS  Google Scholar 

  97. Dixon JB, Bhathal PS, Hughes NR, O’Brien PE. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology. 2004;39(6):1647–54.

    PubMed  Google Scholar 

  98. Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, Lai CL, et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010;52(3):886–93.

    PubMed  CAS  Google Scholar 

  99. George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, Di Bisceglie AM. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology. 2009;49(3):729–38.

    PubMed  CAS  PubMed Central  Google Scholar 

  100. Hoganson DD, Chen J, Ehman RL, Talwalkar JA, Michet CJJ, Yin M, et al. Magnetic resonance elastography for liver fibrosis in methotrexate treatment. Open J Rheumatol Autoimmune Dis. 2012;2:6–13.

    Google Scholar 

  101. Serai SD, Wallihan DB, Venkatesh SK, Ehman RL, Campbell KM, Sticka J, et al. Magnetic resonance elastography of the liver in patients status-post fontan procedure: feasibility and preliminary results. Congenit Heart Dis. 2014;9(1):7–14.

    PubMed  Google Scholar 

  102. Lee VS, Miller FH, Omary RA, Wang Y, Ganger DR, Wang E, et al. Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients. Transplantation. 2011;92(5):581–6.

    PubMed  Google Scholar 

  103. Kamphues C, Klatt D, Bova R, Yahyazadeh A, Bahra M, Braun J, et al. Viscoelasticity-based magnetic resonance elastography for the assessment of liver fibrosis in hepatitis C patients after liver transplantation. Rofo. 2012;184(11):1013–9.

    PubMed  CAS  Google Scholar 

  104. Mariappan YK, Venkatesh SK, Glaser JK, McGee KP, Ehman RL, editors. MR elastography of liver with iron overload: development, evaluation and preliminary clinical experience with improved spin echo and spin echo EPI sequences. In: The 21st annual conference of international society for magnetic resonance in medicine; 2013; Salt Lake City, Utah.

    Google Scholar 

  105. Motosugi U, Ichikawa T, Amemiya F, Sou H, Sano K, Muhi A, et al. Cross-validation of MR elastography and ultrasound transient elastography in liver stiffness measurement: discrepancy in the results of cirrhotic liver. J Magn Reson Imaging. 2012;35(3):607–10.

    PubMed  Google Scholar 

  106. Oudry J, Chen J, Glaser K, Miette V, Sandrin L, Ehman R. Cross-validation of magnetic resonance elastography and ultrasound-based transient elastography: a preliminary phantom study. J Magn Reson Imaging. 2009;30(5):1145–50.

    PubMed  PubMed Central  Google Scholar 

  107. Yoon JH, Lee JM, Woo HS, Yu MH, Joo I, Lee ES, et al. Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individuals. Korean J Radiol. 2013;14(2):202–12.

    PubMed  PubMed Central  Google Scholar 

  108. Guo Y, Parthasarathy S, Goyal P, McCarthy RJ, Larson AC, Miller FH. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging. 2014. (doi:10.1007/s00261-014-0137-6).

  109. Venkatesh SK, Teo LLS, Ang BWL, Ehman RL, editors. Non-invasive detection of liver fibrosis: comparison of MR elastography with diffusion weighted MR imaging. In: Proceedings of ECR 2010; Vienna: European Society of Radiology; 2010.

    Google Scholar 

  110. Wang Y, Ganger DR, Levitsky J, Sternick LA, McCarthy RJ, Chen ZE, et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol. 2011;196(3):553–61.

    PubMed  PubMed Central  Google Scholar 

  111. Wang QB, Zhu H, Liu HL, Zhang B. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology. 2012;56(1):239–47.

    PubMed  Google Scholar 

  112. Choi YR, Lee JM, Yoon JH, Han JK, Choi BI. Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis. Invest Radiol. 2013;48(8):607–13.

    PubMed  CAS  Google Scholar 

  113. Motosugi U, Ichikawa T, Muhi A, Sano K, Morisaka H, Ichikawa S, et al. Magnetic resonance elastography as a predictor of insufficient liver enhancement on gadoxetic acid-enhanced hepatocyte-phase magnetic resonance imaging in patients with type C hepatitis and Child-Pugh class A disease. Invest Radiol. 2012;47(10):566–70.

    PubMed  CAS  Google Scholar 

  114. Noren B, Dahlqvist O, Lundberg P, Almer S, Kechagias S, Ekstedt M, et al. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy. Eur J Radiol. 2008;66(2):313–20.

    PubMed  Google Scholar 

  115. Corbin IR, Ryner LN, Singh H, Minuk GY. Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2004;287(2):G379–84.

    PubMed  CAS  Google Scholar 

  116. Dezortova M, Taimr P, Skoch A, Spicak J, Hajek M. Etiology and functional status of liver cirrhosis by 31P MR spectroscopy. World J Gastroenterol. 2005;11(44):6926–31.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA

    Sudhakar K. Venkatesh M.D., F.R.C.R.

Authors
  1. Sudhakar K. Venkatesh M.D., F.R.C.R.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sudhakar K. Venkatesh M.D., F.R.C.R. .

Editor information

Editors and Affiliations

  1. Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA

    Sudhakar K. Venkatesh

  2. Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA

    Richard L. Ehman

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Venkatesh, S.K. (2014). Clinical Applications of Liver Magnetic Resonance Elastography: Chronic Liver Disease. In: Venkatesh, S., Ehman, R. (eds) Magnetic Resonance Elastography. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1575-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1575-0_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1574-3

  • Online ISBN: 978-1-4939-1575-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation